ADM and Sepsis: Among several candidate biomarkers of sepsis that have emerged in recent years, this review provides existing evidence on the potential clinical utility of two novel biomarkers, adrenomedullin in its bio-active form (bio-ADM) and dipeptidyl peptidase 3 (DPP3).